[pressrelease]legochembiosciences receives uspatent for its own proprietary adc platform technology "conjuall".
legochembiosciencesreceivesuspatentforitsownproprietaryadcplatformtechnologyconjualltm.daejeon,april13,2017legochembioscienses(“lcb”)isabiopharmaceuticalcompanyfocusingontheresearch&developmentofadcs,basedindaejeonsouthkorea,announcedtodaythatthecompanywasawardedu.s.patentno.14517616,entitled“antibodyactiveagentconjugatesandmethodsofuse”.thepatentillustratesthecompany’sconjualltm technology,legochem’sproprietaryadcplatformwhichenablesthedesignofhomogeneousplasmastableadcswiththepotentialforimprovedpayloaddeliverytocancercells. thispatentprovideslcbcomprehensivecoverageintheunitedstatesforitsadcplatformtechnology. dr.yeongsoo oh,seniorvicepresident&chieftechnologyofficeroflcbsaid,“thispatentfurtherstrengthenslcb’scompetitiveadvantageinthefieldofresearchanddevelopmentofnextgenerationadcs.theuseofourtechnologywilladdress significantunmetneedsofcurrentadctechnologies.lcbhasbeensuccessfullydevelopingglobalpartnershipsthroughthepotentialofitsproprietaryadcplatformtechnology.in2015,lcboutlicensed anantiher2adcmoleculetofosunpharmaandinjanuary2017,signedaresearchlicensingdealwithtakeda, toevaluatenextgenerationadccandidates. aboutlegochembioscienceslegochembiosciencesisabiopharmaceuticalcompanyfocusingonthedevelopmentofnextgenerationnoveltherapeuticsutilizingitsproprietarymedicinaldrugdiscoverytechnologylegochemistry™&adcplatformtechnologyconjuall™. sinceitsfoundationin2006,lcbhasfocusedontheresearchanddevelopmentofadc(antibodydrugconjugates),antibiotics,anticoagulantsandanticancertherapeuticsbasedonitsproprietaryplatformtechnologies.aboutconjualltmconjualltm isanextgenerationadcplatformtechnologyutilizingnovellinkerchemistrycombinedwithsitespecificenzymaticconjugation.ourplatformprovidessolutionsforsitespecificconjugation,linkerstabilityandefficientpayloadreleasewhicharethreemajorunmetneedsinadcdevelopment. forlegochembiosciencesbdenquiriesjeiwookchae,chiefbusinessdevelopmentofficertel:+82428610688email:bd@legochembio.com media&investorsenquirieswooshikkim,managertel:+827048113260